Medullary Thyroid Cancer (MTC)

Also known as: Medullary thyroid cancer / Medullary Thyroid Carcinoma / C cell carcinoma / Medullary carcinoma of thyroid

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00188Bortezomib1 / 2Terminated1
DB00145Glycine1 / 2Completed1
DB05381Histamine1 / 2Completed1
DB00836Loperamide1 / 2Unknown Status1
DB13017Rovalpituzumab Tesirine1 / 2Terminated1
DB05294Vandetanib1 / 2Active Not Recruiting1
DB05294Vandetanib1 / 2Terminated1
DB01590Everolimus2Completed1
DB14509Lithium carbonate2Terminated1
DB09079Nintedanib2Active Not Recruiting1
DB06663Pasireotide2Completed1
DB09037Pembrolizumab2Suspended1
DB00398Sorafenib2Withdrawn1
DB11885Anlotinib2 / 3Completed1
DB08875Cabozantinib3Not Yet Recruiting1
DB05294Vandetanib3Active Not Recruiting1
DB05294Vandetanib3Not Yet Recruiting1
DB05153Cabozantinib4Recruiting1
DB08875Cabozantinib4Recruiting1
DB08875CabozantinibNot AvailableApproved for Marketing1
DB14554DotatateNot AvailableNo Longer Available1